Artificial-intelligence-based Reporting Technology for Endoscopy Monitoring and Imaging System
NCT ID: NCT06094270
Last Updated: 2025-04-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
147 participants
OBSERVATIONAL
2023-12-19
2024-03-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study on the Effectiveness of AI-assisted Colonoscopy in Improving the Effect of Colonoscopy Training for Trainees
NCT04912037
Evaluate the Effects of An AI System on Colonoscopy Quality of Novice Endoscopists
NCT05323279
Artificial Intelligence Performance in Colonoscopy in Daily Practice
NCT04837599
AI-assisted Colonoscopy Report System In Improving Reporting Quality
NCT05829590
AI Assistance in GI Endoscopy Recovery Assessment
NCT06923059
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In this observational study, the withdrawal time for the examinations of all recruited patients is estimated by both the physician and the AI method. The study does not relate to any particular indication, and any patient that is appointed for a colonoscopy and does not meet the exclusion criteria can be recruited. The AI method operates in the background, having no influence on the examination's process, or outcome. The standard procedure requires physicians to estimate the withdrawal time and document it in the examination report. Simultaneously, the proposed AI method also computes the withdrawal time for all patients in the background, without affecting the physician, the examination, or the outcomes of the examination. Importantly, the physician remains blinded to the AI model's output.
To establish the gold standard withdrawal time, manual calculations will be performed using the recorded examination data for all patients. This gold standard is used for evaluating errors in withdrawal time estimation made by both the physician and the AI method. Subsequently, a comparative analysis is conducted to assess the disparities between the physician's estimations and those of the AI method.
Furthermore, the AI method captures characteristic images of anatomical landmarks and notable events, such as polyp resections, during the examination. A panel of certified endoscopists will rigorously evaluate the quality and relevance of these selected images.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental: Intervention arm
All patients within the study are included in the intervention arm: The withdrawal time for the interventions for all patients is documented by the physician and the proposed AI system.
EndoMind
Withdrawal time is calculated and an image report is generated using the EndoMind system.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
EndoMind
Withdrawal time is calculated and an image report is generated using the EndoMind system.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Scheduled for colonoscopy
Exclusion Criteria
* Inflammatory Bowel Disease
* Familial Polyposis Syndrome
* Patient after radiation/resection of colonic parts
Data level
* Endoscopic recordings started after beginning of withdrawal.
* Examination recordings stopped before the end of the examination.
* Examinations with corrupt video signal
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wuerzburg University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universitätsklinikum Würzburg
Würzburg, Bavaria, Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Kafetzis I, Sodmann P, Herghelegiu BE, Pauletti M, Brand M, Schottker K, Zoller WG, Albert J, Meining A, Hann A. A Prospective Study Evaluating an Artificial Intelligence-Based System for Withdrawal Time Measurement. Endoscopy. 2025 Oct 13. doi: 10.1055/a-2721-6798. Online ahead of print.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AI03
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.